NBY News and Press, NovaBay Pharmaceuticals Inc. From 08/09/19

NovaBay Pharmaceuticals ( NBY -14.8% ) is down on below-average volume on the heels of its agreement to sell ~4.2M common shares and accompanying unregistered five-year warrants to purchase up to the same number of shares at $1.15 to institutional investors at $1 per share and warrant. C...

EMERYVILLE, Calif., Aug. 09, 2019 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, today announced that it has entered into a securities purchase agreement with...

EMERYVILLE, Calif., Aug. 09, 2019 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova for the domestic eye care market, today announced that it has entered into a securities purchase agreement with...

The following slide deck was published by NovaBay Pharmaceuticals, Inc. in conjunction with their 2019 Q2 earnings Read more ...

NovaBay Pharmaceuticals, Inc. (NBY) Q2 2019 Results Conference Call August 8, 2019 4:30 PM ET Company Participants Jason Raleigh – Chief Financial Officer Jody Cain – Investor Relations-LHA Justin Hall – President and Chief Executive Officer Conference Cal...

NovaBay (NYSEMKT: NBY ): Q2 GAAP EPS of -$0.14 misses by $0.01 . More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Avenova ® sales increase 9% and operating expenses decline 47% over the 2019 first quarter Conference call to be held Thursday August 8, 2019 at 4:30 p.m. Eastern time NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on co...

McDermott International (NYSE: MDR )  -36%  on Q2 earnings . More news on: McDermott International, Inc., TDH Holdings, Inc., SS&C Technologies Holdings, Inc., Stocks on the move, Read more ...

Nano cap NovaBay Pharmaceuticals ( NBY +37.3% ) is up on almost a 4x surge in volume after reporting Q2 results this morning. Sales were $1.8M, down over  35%  from a year ago. Aenova sales were up  9%  sequentially to $1.6M. More news on: NovaBay Pharmaceuticals, I...

Gainers:  NovaBay Pharmaceuticals (NYSEMKT: NBY ) +34% . Medley Management (NYSE: MDLY ) +33% . Pieris Pharmaceuticals (NASDAQ: PIRS ) +24% . Daxor (NYSEMKT: DXR ) +18% . Oasmia Pharmaceutical AB (NASDAQ: OASM ) +17% . Acasti Pharma (NASDAQ: ACST ) +15% . Mylan N.V. (NASDAQ: MYL...